FDA review favors first drug for HIV prevention (Update)
(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
HIV & AIDS
May 08, 2012 |
not rated yet |
0
Indian drug giant Cipla slashes cancer drug prices
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
Medications
May 04, 2012 |
4.9 / 5 (9) |
0
Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Tr ...
HIV & AIDS
May 02, 2012 |
5 / 5 (1) |
0
Anti-HIV drug use during pregnancy does not affect infant size, birth weight
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens ...
HIV & AIDS
May 02, 2012 |
not rated yet |
0
|
Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies
In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms ...
HIV & AIDS
Apr 25, 2012 |
not rated yet |
0
|
Pill to block HIV slated for testing
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.
HIV & AIDS
Apr 23, 2012 |
not rated yet |
0
Cocaine and heroin users who received testing, counseling less likely to have unprotected sex
Voluntary testing and counseling (VT/C) for HIV or sexually transmitted infections (STI) among cocaine and heroin users who were treated in the emergency department (ED), accompanied by referral to drug treatment, was associated ...
Addiction
Apr 17, 2012 |
not rated yet |
0
Giving preventive drug to men at high risk for HIV would be cost-effective, study shows
A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford University researchers conclude in a new study.
HIV & AIDS
Apr 16, 2012 |
not rated yet |
0
|
Sanofi teams up with India to make cheap ARVs in S.Africa
French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.
Medications
Mar 30, 2012 |
not rated yet |
0
Early temporary treatment for HIV can delay the time to long-term treatment
A study in this week's PLoS Medicine suggests that when people are first infected with HIV (primary HIV infection), temporary treatment with antiretroviral drugs (cART) for 24 weeks can delay the need to restart treatment during ...
HIV & AIDS
Mar 27, 2012 |
not rated yet |
0
Study finds HIV-infected men at risk for spreading HIV despite taking HAART
Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men ...
HIV & AIDS
Mar 27, 2012 |
3 / 5 (1) |
0
Bevacizumab active in HIV-linked Kaposi's sarcoma
(HealthDay) -- For patients with HIV-associated Kaposi's sarcoma (HIV-KS), bevacizumab is tolerated and induces a response in some patients, according to a study published online March 19 in the Journal of ...
Cancer
Mar 20, 2012 |
not rated yet |
0
Russia HIV infections rise 5% in 2011: official
Russia in 2011 saw a rise of five percent in the number of new HIV infections to 62,000 cases amid worrying signs that heterosexuals and women are increasingly at risk, its chief doctor said Monday.
HIV & AIDS
Mar 12, 2012 |
not rated yet |
0
Drug helps purge hidden HIV virus, study shows
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
HIV & AIDS
Mar 08, 2012 |
4.8 / 5 (5) |
0
Vaccination strategy may hold key to ridding HIV infection from immune system
Using human immune system cells in the lab, AIDS experts at Johns Hopkins have figured out a way to kill off latent forms of HIV that hide in infected T cells long after antiretroviral therapy has successfully stalled viral ...
Immunology
Mar 08, 2012 |
5 / 5 (2) |
0
|
